Eyepoint Pharmaceuticals Inc
EYPT
$3.44+3.78%
Delayed · as of Sep 29, 2026, 3:45 PM ET
Mkt cap
$1.10B
EV/Sales
31.9
P/E ratio
N/A
FY2025 Revenue
$31.37M
EPS (TTM)
$-3.75
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-739.42%
Beta
N/A
Div yield
N/A
Sector
Healthcare
No recent filings in cache.
Eyepoint Pharmaceuticals Inc (EYPT) is a biotechnology company listed on NASDAQ.
Latest reported EYPT revenue for 2025-12-31 was $31.4M. Net income was -$232.0M. Revenue was down 27.5% from 2024-12-31 to 2025-12-31. EYPT currently screens at market cap $1.10B.
Use this EYPT research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full EYPT income, balance, and cash tables.
Eyepoint Pharmaceuticals Inc (EYPT) is a biotechnology company in the Healthcare sector.
Latest cached Eyepoint Pharmaceuticals Inc (EYPT) revenue for Dec 31, 2025 was $31.4M. Net income was -$232.0M. Statements: https://lician.com/financials/eypt
Eyepoint Pharmaceuticals Inc (EYPT) market capitalization is $1.10B on the latest cached snapshot.
Eyepoint Pharmaceuticals Inc (EYPT) cached previous close $3.31; day range $3.30 – $3.50; volume 1,577,947. Session quote: https://lician.com/quote/eypt